Michiel Reessink

Michiel Reessink is a seasoned executive in the field of laboratory automation and bioinformatics, currently serving as the Chief Commercial Officer at MolGen since September 2024. Previously, Michiel held key leadership roles at Velsera, including Vice President of Clinical Partnerships and Head of International Laboratory and Specialty Sales, where the focus was on advancing precision medicine. Prior experience includes serving as Chief Commercial Officer and Vice President of Global Sales at UgenTec, specializing in diagnostics software, and various sales and business development positions at GENALICE and PerkinElmer. Michiel's educational background includes studies at Saxion University of Applied Sciences and HAN University of Applied Sciences.